Understanding how heterochromatin affects telomere function and maintenance

Deciphering the role of heterochromatin in telomere function and maintenance mechanisms

NIH-funded research University of Colorado · NIH-11086815

This study is looking at how certain structures at the ends of our chromosomes help protect our DNA and keep our cells healthy, which could lead to better ways to understand aging and cancer for everyone.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Colorado NIH-funded
Lab location1 site (Boulder, UNITED STATES)
Project IDNIH-11086815 on NIH RePORTER

What this research studies

This research investigates the role of heterochromatin at telomeres, which are protective structures at the ends of chromosomes. By examining how these chromatin structures influence telomere function, the research aims to uncover mechanisms that could prevent DNA damage and cellular aging. The approach involves studying the interactions between telomeres and specific proteins that bind to them, which may reveal new insights into how cells maintain their stability and prevent cancerous growth. Patients may benefit from findings that enhance our understanding of aging and cancer biology.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals experiencing age-related conditions or those with a family history of cancer.

Not a fit: Patients with acute, non-age-related conditions or those without any genetic predisposition to telomere dysfunction may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing age-related diseases and cancer by improving telomere maintenance.

How similar studies have performed: Previous research has shown promising results in understanding telomere biology, indicating that this area of study has potential for significant breakthroughs.

Where this research is happening

Boulder, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancerous
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.